AME

The Critical Facts About AMETEK Today

Shares of AMETEK have moved 0.3% today, and are now trading at a price of $157.22. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 429,331 compared to the stock's average volume of 1,009,588.

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. Based in Berwyn, United States the company has 19,600 full time employees and a market cap of $36,234,129,408. AMETEK currently offers its equity investors a dividend that yields 0.6% per year.

The company is now trading -3.66% away from its average analyst target price of $163.18 per share. The 13 analysts following the stock have set target prices ranging from $155.0 to $180.0, and on average give AMETEK a rating of buy.

Over the last year, AME shares have gone up 46.3%, which represents a difference of 26.0% when compared to the S&P 500. The stock's 52 week high is $158.61 per share whereas its 52 week low is $106.17. Based on AMETEK's compound average gross margins growth rate of 0.2% over the last 4 years, its core business remains strong and the stock price may maintain this level of performance.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-12-31 6,150,530 4,005,261 34.88 1.16
2021-12-31 5,546,514 3,633,900 34.48 1.41
2020-12-31 4,540,029 2,996,515 34 -1.88
2019-12-31 5,158,557 3,370,897 34.65 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS